Related Experiment Video
Updated: Jun 9, 2026

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
Published on: April 16, 2013
IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype
Nadine Wolgast1,2,3, Thomas Beder1,2,3, Mayukh Mondal3,4,5
1Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.
We developed IntegrateALL, a reproducible RNA-seq pipeline for B-cell acute lymphoblastic leukemia (B-ALL) classification. This tool integrates gene expression, genomic drivers, and karyotyping for accurate molecular subtyping.
Area of Science:
- Genomics
- Bioinformatics
- Oncology
Background:
- RNA-sequencing (RNA-seq) is crucial for diagnosing B-cell precursor acute lymphoblastic leukemia (B-ALL).
- Existing expression-based classifiers achieve high accuracy (~95%) but lack reproducible end-to-end solutions integrating genomic drivers and virtual karyotyping.
Purpose of the Study:
- To develop IntegrateALL, a standardized Snakemake pipeline for comprehensive RNA-seq analysis in B-ALL.
- To integrate expression-based subtype prediction, gene fusion/SNV calling, and virtual karyotyping for robust molecular characterization.
Main Methods:
- Developed IntegrateALL, a Snakemake pipeline for end-to-end RNA-seq analysis from FASTQ to subtype assignment.
- Introduced KaryALL, a machine learning classifier for distinguishing B-ALL ploidy subtypes using expression and minor allele frequency (RNASeqCNV).
- Validated RNA-based karyotyping against SNP-array data.
Main Results:
- IntegrateALL achieved unambiguous subtype assignments in 81.5% of 774 B-ALL cases, integrating gene expression with defining drivers.
- KaryALL demonstrated high accuracy (0.98) and F1 score (0.96) for ploidy classification on 615 independent test samples.
- Analysis of 1210 patients revealed 2.6% harbored dual subtype-defining drivers, including unexpected combinations.
Conclusions:
- IntegrateALL provides an adaptable, reproducible workflow for molecular B-ALL characterization.
- The pipeline systematically integrates genomic drivers and gene regulation for improved diagnostic accuracy.
- Findings highlight the complexity of B-ALL pathogenesis, including dual-driver events and potential oncogenic hierarchies.
More Related Videos
12:44Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014
05:07Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes
Published on: November 7, 2025